1 |
Abp 959 |
- |
- |
- |
- |
062 1件: 62 💬 |
2 |
Abp 959 - biosimilar to eculizumab |
Eculizumab |
1件: D03940 D03940 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 1件: 62 💬 |
3 |
Abp 959 - proposed biosimilar to eculizumab |
Eculizumab |
1件: D03940 D03940 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 1件: 62 💬 |
4 |
Ach-0144471 |
- |
- |
- |
- |
062 3件: 62, 222, 223 💬 |
5 |
Ach-0145228 |
- |
- |
- |
- |
062 1件: 62 💬 |
6 |
Aln-62643 |
- |
- |
- |
- |
062 1件: 62 💬 |
7 |
Aln-cc5 |
- |
- |
- |
- |
062 3件: 62, 66, 109 💬 |
8 |
Alxn1102 |
- |
- |
- |
- |
062 1件: 62 💬 |
9 |
Alxn1103 |
- |
- |
- |
- |
062 1件: 62 💬 |
10 |
Alxn1210 |
- |
- |
- |
- |
002 5件: 2 , 11, 13, 62, 109 💬 |
11 |
Alxn2040 (ach-0144471) |
- |
- |
- |
- |
062 2件: 62, 222 💬 |
12 |
Alxn2050 |
- |
- |
- |
- |
062 1件: 62 💬 |
13 |
Anti-c5 antibody |
- |
- |
- |
- |
011 4件: 11, 14, 62, 109 💬 |
14 |
Anti-thymocyte globulin |
- |
- |
- |
- |
011 18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬 |
15 |
Apl-2 |
- |
- |
- |
- |
061 5件: 61, 62, 66, 222, 223 💬 |
16 |
Bcd-148 |
- |
- |
- |
- |
062 1件: 62 💬 |
17 |
Bcx9930 |
- |
- |
- |
- |
062 1件: 62 💬 |
18 |
Bcx9930 hydrochloride |
- |
- |
- |
- |
062 1件: 62 💬 |
19 |
Bryostatin 1 |
Bryostatin 1 |
- |
- |
- |
062 1件: 62 💬 |
20 |
C5 inh mab, sky59, ro/ch7092230 |
- |
- |
- |
- |
062 1件: 62 💬 |
21 |
C5 inhibitor |
- |
- |
- |
- |
062 1件: 62 💬 |
22 |
C5 inhibitor background therapy |
- |
- |
- |
- |
062 1件: 62 💬 |
23 |
Campath |
- |
- |
- |
- |
019 12件: 19, 20, 49, 51, 60, 62, 65, 164, 234, 283, 285, 326 💬 |
24 |
Campath, chemo and/or tbi allo sct |
- |
- |
- |
- |
060 3件: 60, 62, 283 💬 |
25 |
Coversin |
Nomacopan |
1件: D11473 D11473 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 2件: 62, 109 💬 |
26 |
Crovalimab |
Crovalimab |
1件: D11696 D11696 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 1件: 62 💬 |
27 |
Cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
28 |
Cyclosporin |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
038 17件: 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326 💬 |
29 |
Cyclosporin a |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
046 11件: 46, 49, 53, 56, 60, 62, 63, 93, 95, 113, 164 💬 |
30 |
Cyclosporin a+glucocorticoids |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 2件: 60, 62 💬 |
31 |
Cyclosporine |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
32 |
Cytoreductive regimen followed by a cd34+e- selected allogeneic stem cell transplant |
- |
- |
- |
- |
062 1件: 62 💬 |
33 |
Danicopan |
Danicopan |
1件: D11641 D11641 💬 |
CFD 1件: CFD 💬 |
Complement and coagulation cascades 3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection |
062 2件: 62, 222 💬 |
34 |
Danicopan (alxn2040) |
Danicopan |
1件: D11641 D11641 💬 |
CFD 1件: CFD 💬 |
Complement and coagulation cascades 3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection |
062 1件: 62 💬 |
35 |
Device: miltenyi biotec clinimacs |
- |
- |
- |
- |
062 2件: 62, 326 💬 |
36 |
Device: miltenyi clinimacs |
- |
- |
- |
- |
062 2件: 62, 65 💬 |
37 |
Dextran |
Dextran |
1件: D00060 D00060 💬 |
- |
- |
002 5件: 2 , 62, 79, 96, 97 💬 |
38 |
Eculizumab |
Eculizumab |
1件: D03940 D03940 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
011 8件: 11, 13, 14, 61, 62, 109, 222, 223 💬 |
39 |
Elizaria® |
- |
- |
- |
- |
062 1件: 62 💬 |
40 |
Fc- and cdr-modified humanised monoclonal antibody against c5 |
- |
- |
- |
- |
011 3件: 11, 62, 109 💬 |
41 |
Filgrastim |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 27件: 2 , 6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
42 |
Fludarabine |
Fludarabine |
2件: D01907 D01907, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 💬 |
43 |
Fludarabine phosphate |
Fludarabine |
2件: D01907 D01907, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
028 11件: 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285 💬 |
44 |
G-csf |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 16件: 2 , 6 , 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬 |
45 |
Glucocorticoids |
- |
- |
- |
- |
040 8件: 40, 41, 43, 44, 60, 62, 75, 300 💬 |
46 |
H5g1.1-mab |
- |
- |
- |
- |
013 3件: 13, 50, 62 💬 |
47 |
Human monoclonal antibody directed against complement 5 protein |
- |
- |
- |
- |
062 1件: 62 💬 |
48 |
Iron dextran |
Dextran |
2件: D00060 D00060, D02141 D02141 💬 |
- |
- |
062 1件: 62 💬 |
49 |
Iron sucrose |
Iron sucrose |
2件: D00025 D00025, D04616 D04616 💬 |
- |
- |
062 3件: 62, 96, 97 💬 |
50 |
L04aa25 |
- |
- |
- |
- |
062 1件: 62 💬 |
51 |
Levamisole |
Levamisole |
2件: D00750 D00750, D08114 D08114 💬 |
- |
- |
060 3件: 60, 61, 62 💬 |
52 |
Levamisole+cyclosporin a+glucocorticoids |
Cyclosporine |
3件: D00184 D00184, D00750 D00750, D08114 D08114 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 2件: 60, 62 💬 |
53 |
Lfg316 |
- |
- |
- |
- |
062 1件: 62 💬 |
54 |
Lnp023 |
- |
- |
- |
- |
062 3件: 62, 66, 222 💬 |
55 |
Melphalan |
Melphalan |
1件: D00369 D00369 💬 |
- |
- |
011 15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬 |
56 |
Methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
57 |
Mycophenolate |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 34件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
58 |
Mycophenolate mofetil |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 32件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
59 |
Myeloablative preparative regimen |
- |
- |
- |
- |
062 3件: 62, 65, 284 💬 |
60 |
No |
- |
- |
- |
- |
046 3件: 46, 62, 299 💬 |
61 |
Other: blood collection for measurement of eculizumab peak concentrations |
Eculizumab |
1件: D03940 D03940 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 1件: 62 💬 |
62 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 21件: 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
63 |
Other: pharmacological study |
- |
- |
- |
- |
028 7件: 28, 34, 62, 74, 89, 232, 331 💬 |
64 |
Other: standard of care (soc) |
- |
- |
- |
- |
062 1件: 62 💬 |
65 |
Pegcetacoplan |
- |
- |
- |
- |
062 2件: 62, 222 💬 |
66 |
Pegcetacoplan (apl-2) |
- |
- |
- |
- |
002 2件: 2 , 62 💬 |
67 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 30件: 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
68 |
Procedure: allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
028 8件: 28, 51, 60, 62, 65, 164, 284, 285 💬 |
69 |
Procedure: allogeneic stem cell transplantation |
- |
- |
- |
- |
019 3件: 19, 20, 62 💬 |
70 |
Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
028 6件: 28, 51, 60, 62, 65, 285 💬 |
71 |
Procedure: peripheral blood stem cell transplantation |
- |
- |
- |
- |
011 11件: 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285 💬 |
72 |
Procedure: stem cell transplantation |
- |
- |
- |
- |
019 6件: 19, 51, 60, 62, 65, 326 💬 |
73 |
Ra101495 |
- |
- |
- |
- |
062 1件: 62 💬 |
74 |
Ra101495 sodium |
- |
- |
- |
- |
062 1件: 62 💬 |
75 |
Radiation: total-body irradiation |
- |
- |
- |
- |
028 9件: 28, 51, 60, 62, 65, 96, 283, 284, 285 💬 |
76 |
Ravulizumab |
Ravulizumab |
1件: D11054 D11054 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
002 5件: 2 , 11, 13, 62, 109 💬 |
77 |
Reduced intensity preparative regimen |
- |
- |
- |
- |
062 3件: 62, 65, 284 💬 |
78 |
Reduced toxicity ablative regimen |
- |
- |
- |
- |
062 3件: 62, 65, 284 💬 |
79 |
Regn3918 |
- |
- |
- |
- |
062 1件: 62 💬 |
80 |
Ro7112689 |
- |
- |
- |
- |
062 1件: 62 💬 |
81 |
Ro7112689/f01 |
- |
- |
- |
- |
062 1件: 62 💬 |
82 |
Ro7112689/f03-01 |
- |
- |
- |
- |
062 1件: 62 💬 |
83 |
Ro7112689/f03-03 |
- |
- |
- |
- |
062 1件: 62 💬 |
84 |
Rva576 |
- |
- |
- |
- |
062 3件: 62, 109, 162 💬 |
85 |
Rva576 (coversin) |
Nomacopan |
1件: D11473 D11473 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 2件: 62, 109 💬 |
86 |
Sargramostim |
Sargramostim |
1件: D05803 D05803 💬 |
CSF2RA 1件: CSF2RA 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
006 7件: 6 , 28, 60, 62, 96, 229, 285 💬 |
87 |
Sb12 (proposed eculizumab biosimilar) |
Eculizumab |
1件: D03940 D03940 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 1件: 62 💬 |
88 |
Sirolimus |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 35件: 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
89 |
Soliris |
- |
- |
- |
- |
011 7件: 11, 13, 14, 61, 62, 109, 222 💬 |
90 |
Soliris (eculizumab) |
Eculizumab |
1件: D03940 D03940 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 1件: 62 💬 |
91 |
Soliris 300 |
- |
- |
- |
- |
062 1件: 62 💬 |
92 |
Soliris® |
- |
- |
- |
- |
062 1件: 62 💬 |
93 |
Sterile normal saline (0.9% nacl) |
- |
- |
- |
- |
062 3件: 62, 234, 254 💬 |
94 |
Sucrose |
Sucrose |
1件: D00025 D00025 💬 |
- |
- |
062 3件: 62, 96, 97 💬 |
95 |
Synthetic 15-amino-acid macrocyclic peptide |
- |
- |
- |
- |
062 1件: 62 💬 |
96 |
Synthetic 15-amino-acid macrocyclic peptide acylated with a ethyleneglycol24 |
- |
- |
- |
- |
062 1件: 62 💬 |
97 |
Synthetic 15-amino-acid macrocyclic peptide acylated with a ethyleneglycol24 palmitoylated linker |
- |
- |
- |
- |
062 1件: 62 💬 |
98 |
Synthetic 15-amino-acid macrocyclic peptide acylated with a polyethyleneglycol palmitoylated linker |
- |
- |
- |
- |
062 1件: 62 💬 |
99 |
Systematic chemotherapy and antibodies |
- |
- |
- |
- |
062 1件: 62 💬 |
100 |
Systemic chemotherapy and antibodies |
- |
- |
- |
- |
062 2件: 62, 326 💬 |
101 |
Tacrolimus |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
102 |
Ultomiris |
- |
- |
- |
- |
002 4件: 2 , 11, 13, 62 💬 |
103 |
Vari |
- |
- |
- |
- |
062 2件: 62, 274 💬 |
104 |
Zilucoplan |
Zilucoplan |
- |
- |
- |
002 3件: 2 , 11, 62 💬 |
105 |
Zilucoplan (ra101495) |
Zilucoplan |
- |
- |
- |
011 2件: 11, 62 💬 |
106 |
lnp023 hydrochloride salt |
- |
- |
- |
- |
062 3件: 62, 66, 222 💬 |